Table of Content

1. Executive Summary
   1.1. Global Monkeypox (mpox) Diagnosis Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Diagnostic Test Adoption Analysis
   3.2. Disease Epidemiology- Monkeypox (mpox)
   3.3. Regulatory Landscape
   3.4. Value Chain Analysis
   3.5. PESTLE Analysis
   3.6. Porter’s Five Force Analysis
   3.7. Promotional Strategies, By Key Players
4. Global Monkeypox (mpox) Diagnosis Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Mn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
       4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
   4.3. Global Monkeypox (mpox) Diagnosis Market Outlook: Diagnostic Test
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Mn) Analysis, By Diagnostic Test, 2018 - 2022
       4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 - 2031
           4.3.3.1. Antigen Detection Test
           4.3.3.2. Molecular Test
       4.3.4. Market Attractiveness Analysis: Diagnostic Test
   4.4. Global Monkeypox (mpox) Diagnosis Market Outlook: Sample
       4.4.1. Introduction / Key Findings
       4.4.2. Historical Market Size (US$ Mn) Analysis, By Sample, 2018 - 2022
       4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2023 - 2031
           4.4.3.1. Urine
           4.4.3.2. Whole Blood
           4.4.3.3. Skin Lesion Specimen
           4.4.3.4. Others
       4.4.4. Market Attractiveness Analysis: Sample
5. Global Monkeypox (mpox) Diagnosis Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 - 2022
   5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Monkeypox (mpox) Diagnosis Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       6.2.1. By Country
       6.2.2. By Diagnostic Test
       6.2.3. By Sample
   6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       6.3.1. U.S.
       6.3.2. Canada
   6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 - 2031
       6.4.1. Antigen Detection Test
       6.4.2. Molecular Test
   6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2023 - 2031
       6.5.1. Urine
       6.5.2. Whole Blood
       6.5.3. Skin Lesion Specimen
       6.5.4. Others
   6.6. Market Attractiveness Analysis
7. Europe Monkeypox (mpox) Diagnosis Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   7.1. Key Highlights
   7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       7.2.1. By Country
       7.2.2. By Diagnostic Test
       7.2.3. By Sample
   7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       7.3.1. Germany
       7.3.2. France
       7.3.3. U.K.
       7.3.4. Italy
       7.3.5. Spain
       7.3.6. Russia
       7.3.7. Türkiye
       7.3.8. Rest of Europe
   7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 - 2031
       7.4.1. Antigen Detection Test
       7.4.2. Molecular Test
   7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2023 - 2031
       7.5.1. Urine
       7.5.2. Whole Blood
       7.5.3. Skin Lesion Specimen
       7.5.4. Others
   7.6. Market Attractiveness Analysis
8. East Asia Monkeypox (mpox) Diagnosis Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   8.1. Key Highlights
   8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       8.2.1. By Country
       8.2.2. By Diagnostic Test
       8.2.3. By Sample
   8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       8.3.1. China
       8.3.2. Japan
       8.3.3. South Korea
   8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 - 2031
       8.4.1. Antigen Detection Test
       8.4.2. Molecular Test
   8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2023 - 2031
       8.5.1. Urine
       8.5.2. Whole Blood
       8.5.3. Skin Lesion Specimen
       8.5.4. Others
   8.6. Market Attractiveness Analysis
9. South Asia & Oceania Monkeypox (mpox) Diagnosis Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   9.1. Key Highlights
   9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       9.2.1. By Country
       9.2.2. By Diagnostic Test
       9.2.3. By Sample
   9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       9.3.1. India
       9.3.2. Southeast Asia
       9.3.3. ANZ
       9.3.4. Rest of South Asia & Oceania
   9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 - 2031
       9.4.1. Antigen Detection Test
       9.4.2. Molecular Test
   9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2023 - 2031
       9.5.1. Urine
       9.5.2. Whole Blood
       9.5.3. Skin Lesion Specimen
       9.5.4. Others
   9.6. Market Attractiveness Analysis
10. Latin America Monkeypox (mpox) Diagnosis Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   10.1. Key Highlights
   10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       10.2.1. By Country
       10.2.2. By Diagnostic Test
       10.2.3. By Sample
   10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       10.3.1. Brazil
       10.3.2. Mexico
       10.3.3. Rest of Latin America
   10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 - 2031
       10.4.1. Antigen Detection Test
       10.4.2. Molecular Test
   10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2023 - 2031
       10.5.1. Urine
       10.5.2. Whole Blood
       10.5.3. Skin Lesion Specimen
       10.5.4. Others
   10.6. Market Attractiveness Analysis
11. Middle East & Africa Monkeypox (mpox) Diagnosis Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   11.1. Key Highlights
   11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       11.2.1. By Country
       11.2.2. By Diagnostic Test
       11.2.3. By Sample
   11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       11.3.1. GCC Countries
       11.3.2. Egypt
       11.3.3. South Africa
       11.3.4. Northern Africa
       11.3.5. Rest of Middle East & Africa
   11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 - 2031
       11.4.1. Antigen Detection Test
       11.4.2. Molecular Test
   11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Sample, 2023 - 2031
       11.5.1. Urine
       11.5.2. Whole Blood
       11.5.3. Skin Lesion Specimen
       11.5.4. Others
   11.6. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping, By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Abbott Molecular, Inc.
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. Laboratory Corporation of America (Labcorp)
       12.3.3. Cue Health, Inc.
       12.3.4. Quest Diagnostics Nichols Institute
       12.3.5. Cepheid
       12.3.6. DiaCarta, Inc.
       12.3.7. Roche Molecular Systems, Inc.
       12.3.8. Meridian Biosciences
       12.3.9. Vazyme International LLC
       12.3.10. Siemens Healthcare
       12.3.11. MedTech Zone
       12.3.12. Creative Biogene
       12.3.13. Transasia diagnostics
       12.3.14. JOYSBIO (Tianjin) Biotechnology Co., Ltd
       12.3.15. Daan Gene Co., Ltd.
       12.3.16. BD
       12.3.17. CERTEST BIOTEC
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations